ATE150463T1 - Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen - Google Patents

Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen

Info

Publication number
ATE150463T1
ATE150463T1 AT92920743T AT92920743T ATE150463T1 AT E150463 T1 ATE150463 T1 AT E150463T1 AT 92920743 T AT92920743 T AT 92920743T AT 92920743 T AT92920743 T AT 92920743T AT E150463 T1 ATE150463 T1 AT E150463T1
Authority
AT
Austria
Prior art keywords
quinolone
compound
lactam
moiety
steps
Prior art date
Application number
AT92920743T
Other languages
English (en)
Inventor
Ronald Eugene White
Thomas Prosser Demuth Jr
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Application granted granted Critical
Publication of ATE150463T1 publication Critical patent/ATE150463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92920743T 1991-10-01 1992-09-28 Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen ATE150463T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76961591A 1991-10-01 1991-10-01

Publications (1)

Publication Number Publication Date
ATE150463T1 true ATE150463T1 (de) 1997-04-15

Family

ID=25085987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92920743T ATE150463T1 (de) 1991-10-01 1992-09-28 Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen

Country Status (22)

Country Link
US (1) US5281703A (de)
EP (1) EP0606336B1 (de)
KR (1) KR100253825B1 (de)
CN (1) CN1046523C (de)
AT (1) ATE150463T1 (de)
AU (1) AU667837B2 (de)
BR (1) BR9206590A (de)
CA (1) CA2120493A1 (de)
CZ (1) CZ73194A3 (de)
DE (1) DE69218445T2 (de)
DK (1) DK0606336T3 (de)
ES (1) ES2101119T3 (de)
FI (1) FI941490A7 (de)
GR (1) GR3023227T3 (de)
HU (1) HUT67423A (de)
MX (1) MX9205620A (de)
NO (1) NO304599B1 (de)
NZ (1) NZ244557A (de)
PT (1) PT100920B (de)
RU (1) RU2130938C1 (de)
SK (1) SK37594A3 (de)
WO (1) WO1993007154A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
EP0937445B1 (de) * 1993-12-28 2004-03-24 Kao Corporation Vernetzte Zellulosefasern, absorbierende Papiere und absorbierende Elemente, Deckschicht und absorbierende Gegenstände, wobei diese Fasern Verwendung finden
CN1159809A (zh) * 1994-08-02 1997-09-17 普罗克特和甘保尔公司 喹诺酮基内酰胺抗微生物化合物和新型的中间体化合物的制备方法
BR9508514A (pt) * 1994-08-02 1997-12-23 Procter & Gamble Processo para fabricação de compostos antimicrobiais
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (de) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem-Derivate mit einem bicyclischen Substituenten, Verfahren zu ihrer Herstellung und ihre Verwendung
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
WO1999028308A1 (en) * 1997-11-29 1999-06-10 Truett William L Antibiotics and process for preparation
US6437119B1 (en) 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
US6947844B2 (en) * 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) * 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
IN191798B (de) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
ES2213648T3 (es) 2001-03-30 2004-09-01 Dar Al Dawa Development, And Investment Co. Derivados de quinolin-4-ona y su uso como antibioticos.
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
BRPI0408117A (pt) * 2003-03-05 2006-03-01 Rib X Pharmaceuticals Inc compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
EP2716647A3 (de) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Makrocyclische Verbindungen Und Verfahren Zu Deren Herstellung Und Anwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
EP0997466A1 (de) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Antimikrobielle Laktamchinolone
EP0366193A3 (de) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Antimikrobielle Quinolonyllactame
DE68929227T2 (de) * 1988-10-24 2001-05-31 Procter & Gamble Pharmaceuticals, Inc. Antimikrobielle Quinolonyllactamester
ATE176473T1 (de) * 1988-10-24 1999-02-15 Procter & Gamble Pharma Antimikrobielle fluorochinolonylcephemderivate
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
DK0525057T3 (da) * 1990-04-18 2000-07-31 Procter & Gamble Pharma Antimikrobielle quinolonyllactamer

Also Published As

Publication number Publication date
MX9205620A (es) 1993-12-01
FI941490L (fi) 1994-05-02
DE69218445T2 (de) 1997-08-07
FI941490A7 (fi) 1994-05-02
CZ73194A3 (en) 1994-11-16
BR9206590A (pt) 1995-04-25
HU9400940D0 (en) 1994-06-28
FI941490A0 (fi) 1994-03-30
ES2101119T3 (es) 1997-07-01
WO1993007154A1 (en) 1993-04-15
NO304599B1 (no) 1999-01-18
KR100253825B1 (ko) 2000-05-01
PT100920A (pt) 1993-10-29
CA2120493A1 (en) 1993-04-15
NO941108L (no) 1994-05-31
US5281703A (en) 1994-01-25
SK37594A3 (en) 1995-02-08
DE69218445D1 (de) 1997-04-24
NO941108D0 (no) 1994-03-25
AU2693892A (en) 1993-05-03
CN1075146A (zh) 1993-08-11
GR3023227T3 (en) 1997-07-30
PT100920B (pt) 1999-07-30
HUT67423A (en) 1995-04-28
DK0606336T3 (da) 1997-04-14
AU667837B2 (en) 1996-04-18
EP0606336B1 (de) 1997-03-19
NZ244557A (en) 1996-02-27
CN1046523C (zh) 1999-11-17
EP0606336A1 (de) 1994-07-20
RU2130938C1 (ru) 1999-05-27

Similar Documents

Publication Publication Date Title
DE69218445D1 (de) Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
RU94018240A (ru) Способ получения антимикробных хинолониллактамов
ATE117672T1 (de) Verfahren zur herstellung von nitrilen.
CA2238864A1 (en) Method for the synthesis of a benzimidazole compound
DE69231874D1 (de) Verfahren zur herstellung von 4-substituierten azetidinon-derivaten
DE69515882D1 (de) Verfahren zur herstellung von antimikrobiellen verbindungen
ATE168693T1 (de) Verfahren zur herstellung von beta- lactamderivaten und zwischenprodukt für ihre synthese
ATE127809T1 (de) Verfahren zur herstellung von verbindungen zur behandlung der gutartigen prostatahypertrophie.
KR930016425A (ko) 피롤리딘유도체 및 그 제조법
DE3382761D1 (de) Verfahren zur Herstellung von Penem-Verbindungen.
DE69622862D1 (de) Verfahren zur herstellung von zyklischen verbindungen
NO992058L (no) FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler
CA2196539A1 (en) Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
DE69714749D1 (de) Verfahren zur herstellung von 3-amino-2-hydroxy-1-propylethern
NO931105L (no) Fremgangsmaate for fremstilling av et 4-substituert azetidinonderivat
ATE205497T1 (de) Verfahren zur herstellung von 3-norcephem- verbindungen
DE69427100D1 (de) Herstellung von Beta-lactamverbindungen und Zwischenprodukte
DE3864163D1 (de) Beta-lactam-verbindungen und verfahren zu deren herstellung.
ATE210115T1 (de) Verfahren zur herstellung von (1'r,3s,4r)4- acylthioazetidinonen
ATE116288T1 (de) Verfahren zur herstellung von sulfonylisocyanaten.
MY105332A (en) Process for preparing penem esters
ATE226207T1 (de) Verfahren zur herstellung von beta-lactam verbindungen
EP1489070A4 (de) Verfahren zur herstellung optisch aktiver verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee